08
2022
-
11
Sanji Technology Chromatography Microspheres
Author:
With the adjustment of the national industrial structure, supply side reform, and the policies of innovation driven high-quality development to catch up at various stages, the biopharmaceutical sector has always been at the forefront of China's economic development strategy. The tackling of bottleneck engineering technology is the key to the safety and development of the biopharmaceutical industry.
With the adjustment of the national industrial structure, supply side reform, and the policies of innovation driven high-quality development to catch up at various stages, the biopharmaceutical sector has always been at the forefront of China's economic development strategy. The tackling of bottleneck engineering technology is the key to the safety and development of the biopharmaceutical industry.
At present, most of the raw materials of agarose gel microspheres on the market rely on imports. In recent years, China's antibody drugs have ushered in an explosive development. Due to the epidemic situation, policies and other reasons, the supply of imported raw materials is generally affected.
The R&D team of Sanji Technology was established in 2015 and founded in Xiamen Haicang Biological Pharmaceutical Port in 2021. It is an extension of the downstream industrial chain of Lvxin Company, a world-famous agar manufacturer. From the cultivation of agar raw materials to the purification of agarose in agar and the R&D and production of agarose gel microspheres, Sanji Technology has solved the problem of key raw materials for microspheres.
Sanji Technology's parent company, Green New Hydrophilic Colloid Marine Technology Co., Ltd., reached a cooperation agreement with Jimei University and the School of Life and Marine Sciences of Shenzhen University in February 2022 to conduct in-depth research on key technologies for high-value utilization of seaweed.
Sanji Technology and the Structural Immunology Laboratory of the University of Science and Technology of China have signed a strategic cooperation agreement on the research and development project of protein purification fillers, to deeply explore the application of protein purification fillers in the research and development of recombinant proteins, nano antibodies, vaccine drugs, and antibody preparation.
About us
Address: 5th floor, building 12, Xiamen biomedical collaborative innovation and entrepreneurship center, 71 HouXiang Road, Haicang District, Xiamen